Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-038152

Options or other derivatives

  • Director acquired 27,830 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SATO VICKI L Director 2018-06-13 Grant or award · Stock Option (right to buy) +27,830 27,830 D
Loading xslF345X03/doc4.xml…